Cargando…
Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer
SIMPLE SUMMARY: We developed a new labeled mouse cell line to study ovarian cancer. The STOSE mouse cell line was engineered to express a luciferase label to enable real-time tumor monitoring by imaging. We characterized the growth of the cell line in mice and identified the immune cells within the...
Autores principales: | Russell, Shonagh, Lim, Felicia, Peters, Pamela N., Wardell, Suzanne E., Whitaker, Regina, Chang, Ching-Yi, Previs, Rebecca A., McDonnell, Donald P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454869/ https://www.ncbi.nlm.nih.gov/pubmed/36077756 http://dx.doi.org/10.3390/cancers14174219 |
Ejemplares similares
-
Association of Genomic Instability Score, Tumor Mutational Burden, and Tumor-Infiltrating Lymphocytes as Biomarkers in Uterine Serous Carcinoma
por: Bloom, Elizabeth A., et al.
Publicado: (2023) -
Targeting mutant estrogen receptors
por: Wardell, Suzanne E, et al.
Publicado: (2019) -
Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model
por: Nounamo, Bernice, et al.
Publicado: (2017) -
Enhancement of syngeneic murine tumour transplantability by whole body irradiation--a non-immunological phenomenon.
por: Peters, L. J.
Publicado: (1975) -
Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer
por: Liao, John B, et al.
Publicado: (2015)